US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist

13.470
+1.220+9.96%

Close Oct 4 16:00 ET

13.470
0.0000.00%

Post 20:02 ET

1.26BMarket Cap-9485P/E (TTM)

Gyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Total revenue

-13.99%25.23M

8.99%27.17M

10.91%113.45M

29.33M

-0.33%24.93M

14.18%102.29M

25.01M

89.59M

Operating revenue

-13.99%25.23M

8.99%27.17M

10.91%113.45M

--29.33M

-0.33%24.93M

14.18%102.29M

--25.01M

--89.59M

Cost of revenue

-28.51%770K

-12.98%979K

-3.28%4.64M

1.08M

-6.17%1.13M

19.21%4.79M

1.2M

4.02M

Gross profit

-13.44%24.46M

10.03%26.19M

11.61%108.81M

28.25M

-0.04%23.81M

13.94%97.5M

23.82M

85.57M

Operating expense

-8.96%21.19M

5.72%18.12M

1.48%89.6M

23.28M

8.27%17.14M

59.28%88.29M

15.83M

55.43M

Selling and administrative expenses

-9.50%17.84M

9.88%15.94M

5.88%75.82M

--19.71M

5.43%14.51M

48.16%71.61M

--13.76M

--48.33M

-Selling and marketing expense

-19.92%14.41M

-1.77%12.54M

12.76%61.16M

--18M

12.72%12.77M

21.47%54.24M

--11.33M

--44.65M

-General and administrative expense

100.12%3.42M

95.40%3.4M

-15.59%14.66M

--1.71M

-28.52%1.74M

371.86%17.37M

--2.43M

--3.68M

Research and development costs

-5.97%3.36M

-17.19%2.18M

-17.42%13.78M

--3.57M

27.10%2.64M

130.27%16.69M

--2.07M

--7.25M

Other operating expenses

----

---145.28K

Operating profit

-34.42%3.26M

21.11%8.07M

108.77%19.21M

4.97M

-16.52%6.66M

-69.46%9.2M

7.98M

30.13M

Net non-operating interest income expense

39.44%350K

78.26%328K

43.80%1.04M

251K

1,444.62%184K

179.28%726K

-13.68K

259.96K

Non-operating interest income

----

78.26%328K

----

--184K

----

--382.33K

Non-operating interest expense

----

--13.68K

--122.37K

Total other finance cost

-39.44%-350K

----

-43.80%-1.04M

---251K

----

---726K

----

Other net income (expense)

285.21%2.42M

807.45%4.08M

-18,705.03%-97.22M

629K

-1,441.34%-577K

34.45%-517K

-37.43K

-788.66K

Gain on sale of security

--2.91M

--4.29M

---9.26M

----

--239.72K

Special income (charges)

---68K

----

---86.44M

--0

----

--0

----

-Less:Other special charges

----

--83.1M

----

-Gain on sale of business

----

---2.71M

----

--0

----

-Gain on sale of property,plant,equipment

---68K

----

---628K

--0

----

--0

----

Other non- operating income (expenses)

-167.09%-422K

64.30%-206K

-193.62%-1.52M

--629K

-1,441.34%-577K

49.73%-517K

---37.43K

---1.03M

Income before tax

3.09%6.04M

99.03%12.48M

-917.73%-76.97M

5.85M

-20.94%6.27M

-68.21%9.41M

7.93M

29.6M

Income tax

-28.17%1.5M

23.95%2.55M

67.03%8.52M

2.08M

15.40%2.05M

-17.35%5.1M

1.78M

6.17M

Net income

20.37%4.54M

135.59%9.94M

-2,081.46%-85.48M

3.77M

-31.45%4.22M

-81.59%4.31M

6.15M

23.44M

Net income continuous Operations

20.37%4.54M

135.59%9.94M

-2,081.46%-85.48M

--3.77M

-31.45%4.22M

-81.59%4.31M

--6.15M

--23.44M

Minority interest income

-47.31%1.01M

21.79%2.4M

270.43%7.45M

1.92M

1.97M

2.01M

Net income attributable to the parent company

90.39%3.53M

235.65%7.53M

-4,137.05%-92.93M

1.85M

-63.52%2.24M

-90.18%2.3M

6.15M

23.44M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

90.39%3.53M

235.65%7.53M

-4,137.05%-92.93M

1.85M

-63.52%2.24M

-90.18%2.3M

6.15M

23.44M

Basic earnings per share

65.32%0.04

207.16%0.09

-4,790.77%-1.41

0.0242

-63.52%0.0293

-90.18%0.0301

0.0803

0.306

Diluted earnings per share

-58.67%0.01

2.39%0.03

-4,790.77%-1.41

0.0242

-63.52%0.0293

-90.18%0.0301

0.0803

0.306

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Total revenue	-13.99%25.23M	8.99%27.17M	10.91%113.45M	29.33M	-0.33%24.93M	14.18%102.29M	25.01M	89.59M
Operating revenue	-13.99%25.23M	8.99%27.17M	10.91%113.45M	--29.33M	-0.33%24.93M	14.18%102.29M	--25.01M	--89.59M
Cost of revenue	-28.51%770K	-12.98%979K	-3.28%4.64M	1.08M	-6.17%1.13M	19.21%4.79M	1.2M	4.02M
Gross profit	-13.44%24.46M	10.03%26.19M	11.61%108.81M	28.25M	-0.04%23.81M	13.94%97.5M	23.82M	85.57M
Operating expense	-8.96%21.19M	5.72%18.12M	1.48%89.6M	23.28M	8.27%17.14M	59.28%88.29M	15.83M	55.43M
Selling and administrative expenses	-9.50%17.84M	9.88%15.94M	5.88%75.82M	--19.71M	5.43%14.51M	48.16%71.61M	--13.76M	--48.33M
-Selling and marketing expense	-19.92%14.41M	-1.77%12.54M	12.76%61.16M	--18M	12.72%12.77M	21.47%54.24M	--11.33M	--44.65M
-General and administrative expense	100.12%3.42M	95.40%3.4M	-15.59%14.66M	--1.71M	-28.52%1.74M	371.86%17.37M	--2.43M	--3.68M
Research and development costs	-5.97%3.36M	-17.19%2.18M	-17.42%13.78M	--3.57M	27.10%2.64M	130.27%16.69M	--2.07M	--7.25M
Other operating expenses	----	----	----	----	----	----	----	---145.28K
Operating profit	-34.42%3.26M	21.11%8.07M	108.77%19.21M	4.97M	-16.52%6.66M	-69.46%9.2M	7.98M	30.13M
Net non-operating interest income expense	39.44%350K	78.26%328K	43.80%1.04M	251K	1,444.62%184K	179.28%726K	-13.68K	259.96K
Non-operating interest income	----	78.26%328K	----	----	--184K	----	----	--382.33K
Non-operating interest expense	----	----	----	----	----	----	--13.68K	--122.37K
Total other finance cost	-39.44%-350K	----	-43.80%-1.04M	---251K	----	---726K	----	----
Other net income (expense)	285.21%2.42M	807.45%4.08M	-18,705.03%-97.22M	629K	-1,441.34%-577K	34.45%-517K	-37.43K	-788.66K
Gain on sale of security	--2.91M	--4.29M	---9.26M	----	----	----	----	--239.72K
Special income (charges)	---68K	----	---86.44M	--0	----	--0	----	----
-Less:Other special charges	----	----	--83.1M	----	----	----	----	----
-Gain on sale of business	----	----	---2.71M	----	----	--0	----	----
-Gain on sale of property,plant,equipment	---68K	----	---628K	--0	----	--0	----	----
Other non- operating income (expenses)	-167.09%-422K	64.30%-206K	-193.62%-1.52M	--629K	-1,441.34%-577K	49.73%-517K	---37.43K	---1.03M
Income before tax	3.09%6.04M	99.03%12.48M	-917.73%-76.97M	5.85M	-20.94%6.27M	-68.21%9.41M	7.93M	29.6M
Income tax	-28.17%1.5M	23.95%2.55M	67.03%8.52M	2.08M	15.40%2.05M	-17.35%5.1M	1.78M	6.17M
Net income	20.37%4.54M	135.59%9.94M	-2,081.46%-85.48M	3.77M	-31.45%4.22M	-81.59%4.31M	6.15M	23.44M
Net income continuous Operations	20.37%4.54M	135.59%9.94M	-2,081.46%-85.48M	--3.77M	-31.45%4.22M	-81.59%4.31M	--6.15M	--23.44M
Minority interest income	-47.31%1.01M	21.79%2.4M	270.43%7.45M	1.92M	1.97M	2.01M
Net income attributable to the parent company	90.39%3.53M	235.65%7.53M	-4,137.05%-92.93M	1.85M	-63.52%2.24M	-90.18%2.3M	6.15M	23.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	90.39%3.53M	235.65%7.53M	-4,137.05%-92.93M	1.85M	-63.52%2.24M	-90.18%2.3M	6.15M	23.44M
Basic earnings per share	65.32%0.04	207.16%0.09	-4,790.77%-1.41	0.0242	-63.52%0.0293	-90.18%0.0301	0.0803	0.306
Diluted earnings per share	-58.67%0.01	2.39%0.03	-4,790.77%-1.41	0.0242	-63.52%0.0293	-90.18%0.0301	0.0803	0.306
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data